Department of Anesthesiology
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Savarese JJ, Ginsburg S, Braswell L, Kitz RJ.  1979.  Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.. J Pharmacol Exp Ther. 208(3):436-45.
Savarese JJ, Lien CA, Belmont MR, Wastila WB.  1997.  [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].. Anaesthesist. 46(10):840-9.
Savarese JJ, Todd D.  1973.  Letter: Succinylcholine effects in anesthesia.. JAMA. 226(11):1359-60.
Savarese JJ, Wastila WB.  1995.  The future of the benzylisoquinolinium relaxants.. Acta Anaesthesiol Scand Suppl. 106:91-3.
Savarese JJ, Lien CA, Belmont MR.  1995.  The accuracy of the 5%-25% (T1-T3) twitch recovery interval in predicting the speed of spontaneous recovery from mivacurium-induced neuromuscular blockade.. Anesth Analg. 80(1):209-10.
Savarese JJ.  1979.  How may neuromuscular blocking drugs affect the state of general anesthesia? Anesth Analg. 58(6):449-51.
Savarese JJ, Ali HH, Murphy JD, Padget C, Lee CM, Ponitz J.  1975.  Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.. Anesthesiology. 42(1):106-11.
Savarese JJ, McGilvra JD, Sunaga H, Belmont MR, Van Ornum SG, Savard PM, Heerdt PM.  2010.  Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.. Anesthesiology. 113(1):58-73.
Savarese JJ, Thomas GB, Homesley H, Hill CS.  1988.  Rescue factor: a design for evaluating long-acting analgesics.. Clin Pharmacol Ther. 43(4):376-80.
Savarese JJ, Philbin DM.  1979.  Cardiovascular effects of neuromuscular blocking agents.. Int Anesthesiol Clin. 17(1):13-54.
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Savarese JJ, Antonio RP, Ginsburg S.  1975.  Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.. Anesth Analg. 54(5):669-78.
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Savarese JJ, Brinken BW, Zaleske DJ.  1995.  Epiphyseal replacement in a murine model.. J Pediatr Orthop. 15(5):682-90.
Savarese JJ, Lien CA, Belmont MR, Rubin L.  1995.  The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.. Acta Anaesthesiol Scand Suppl. 106:18-22.
Savarese JJ, Berkowitz BA.  1979.  beta-Adrenergic receptor decrease in diabetic rat hearts.. Life Sci. 25(24-25):2075-8.
Savarese JJ.  1975.  Letter: Histamine, d-tubocurarine, and CSF pressure.. Anesthesiology. 42(3):369.
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Savarese JJ.  1974.  Germination studies on pure yeast ascospores.. Can J Microbiol. 20(11):1517-22.
Savarese JJ, Erickson H, Scully SP.  1996.  Articular chondrocyte tenascin-C production and assembly into de novo extracellular matrix.. J Orthop Res. 14(2):273-81.
Savarese JJ, Goldenheim PD, Thomas GB, Kaiko RF.  1986.  Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.. Clin Pharmacokinet. 11(6):505-10.
Savarese JJ.  1979.  The autonomic margins of safety of metocurine and d-tubocurarine in the cat.. Anesthesiology. 50(1):40-6.
Scarpa J.  2023.  Improving liver transplant outcomes with transplant-omics and network biology.. Curr Opin Organ Transplant.
Scarpa JR, DiNatale RG, Mano R, Silagy AW, Kuo F, Irie T, McCormick PJ, Fischer GW, A Hakimi A, Mincer JS.  2020.  Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.. Cancer Res.
Scarpa JR, Montagna G, Plitas G, Gulati A, Fischer GW, Mincer JS.  2023.  Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer.. Front Oncol. 13:1267532.